Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -341.48%-33.39M | 5,122.68%175.69M | -220.94%-58.22M | -185.84%-31.84M | -161.36%-22.18M | -188.30%-7.56M | 109.99%3.36M | -26.90%48.14M | 17.29%37.09M | 229.01%36.15M |
| Net profit before non-cash adjustment | 79.56%26.81M | 95.88%22.08M | 57.20%74.17M | 117.88%27.93M | 32.25%20.04M | 52.48%14.93M | 19.64%11.27M | 70.10%47.18M | 68.15%12.82M | 115.64%15.15M |
| Total adjustment of non-cash items | 52.76%8.23M | 58.37%7.74M | 26.88%23.75M | -21.59%5.87M | 103.29%7.6M | 31.21%5.39M | 44.49%4.89M | 71.13%18.72M | 48.78%7.49M | 38.75%3.74M |
| -Depreciation and amortization | 8.50%3.26M | 25.18%3.58M | 78.44%13.31M | 40.34%4.26M | 55.55%3.2M | 124.79%3M | 175.68%2.86M | 74.07%7.46M | 177.58%3.03M | 74.07%2.05M |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | -1.12%1.59M | -110.54%-169K | --1.82M | --136K | ---206K | -43.44%1.6M | --1.6M | --0 |
| -Assets reserve and write-off | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 5,705.26%1.1M | --199K | --574K |
| -Share of associates | -990.00%-654K | -1,672.09%-676K | -7,266.67%-2.58M | -3,655.41%-2.63M | 47.83%68K | 7.69%-60K | 326.32%43K | 180.00%36K | 772.73%74K | 53.33%46K |
| -Disposal profit | --0 | 99.65%-1K | -88.82%-1.89M | -258.75%-1.09M | 59.23%-285K | ---232K | ---288K | -778.95%-1M | -604.65%-303K | -207.04%-699K |
| -Net exchange gains and losses | 10,046.67%1.52M | 805.71%1.27M | 7,015.00%2.85M | 2,624.21%2.59M | 124.76%103K | -91.80%15K | -21.35%140K | 117.09%40K | 144.81%95K | 10.92%-416K |
| -Remuneration paid in stock | 312.15%1.19M | -74.32%75K | -67.66%963K | -69.44%169K | -68.67%214K | -66.78%288K | -66.63%292K | 256.22%2.98M | 55.77%553K | 91.32%683K |
| -Other non-cash items | 30.37%2.92M | 70.65%3.5M | 46.38%9.52M | 22.81%2.75M | 65.78%2.48M | 53.77%2.24M | 56.21%2.05M | 93.66%6.5M | 123.60%2.24M | 58.98%1.5M |
| Changes in working capital | -145.42%-68.43M | 1,240.18%145.87M | -778.84%-156.14M | -491.24%-65.64M | -388.63%-49.82M | -422.61%-27.88M | 72.47%-12.79M | -165.37%-17.77M | -11.52%16.78M | 145.73%17.26M |
| -Change in receivables | -14.42%-61.99M | 4,782.05%146.07M | -1,479.56%-344.13M | -710.39%-164.25M | -471.40%-128.7M | -443.62%-54.17M | 105.71%2.99M | 145.43%24.95M | 419.24%26.91M | 550.88%34.65M |
| -Change in inventory | 88.94%-1.3M | -667.78%-2.76M | -180.83%-5.99M | -38.11%458K | 227.81%5.63M | -129.46%-11.72M | 98.75%-360K | 173.25%7.41M | 122.05%740K | 47.58%-4.4M |
| -Change in payables | -206.40%-18.02M | 252.15%14.13M | 468.49%128.94M | 5,047.57%105.06M | 175.15%16.23M | 143.73%16.94M | -139.88%-9.29M | -153.77%-34.99M | -89.14%2.04M | -528.70%-21.6M |
| -Changes in other current assets | -38.90%12.88M | -88.46%-11.57M | 529.84%65.05M | 46.45%-6.91M | 562.33%57.03M | 195.16%21.07M | -154.26%-6.14M | -155.78%-15.13M | -208.02%-12.91M | 127.57%8.61M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 9.14%-2.93M | -14.14%-2.04M | -57.84%-10.07M | -39.68%-3.03M | 5.91%-2.02M | -254.84%-3.23M | -55.43%-1.79M | -84.64%-6.38M | -99.08%-2.17M | -133.44%-2.15M |
| Interest received (cash flow from operating activities) | 217.84%1.09M | 28.06%534K | 5.53%1.37M | 7.49%359K | -52.50%256K | 34.12%342K | 139.66%417K | 124.10%1.3M | -39.60%334K | 539K |
| Tax refund paid | -60.82%-3.55M | -86.49%-5.31M | -77.59%-20.55M | -80.76%-8.57M | -116.17%-6.93M | -55.71%-2.21M | -28.91%-2.85M | -77.92%-11.57M | -39.37%-4.74M | -190.74%-3.2M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -206.42%-38.78M | 19,804.78%168.87M | -377.80%-87.47M | -241.18%-43.08M | -198.53%-30.87M | -294.99%-12.66M | 97.67%-857K | -44.25%31.49M | 10.22%30.51M | 204.29%31.33M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -8.73%-12.66M | -463.19%-15.29M | -28.08%-68.23M | -16.11%-24.26M | -489.53%-29.61M | 7.26%-11.64M | 81.66%-2.71M | 61.08%-53.27M | 49.17%-20.89M | 92.35%-5.02M |
| Net intangibles purchase and sale | --788K | ---950K | ---448K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net business purchase and sale | -2,674.19%-26.44M | -6,704.40%-34.02M | -3,257.61%-29.87M | -626.72%-16.42M | -524.67%-12M | -281.20%-953K | ---500K | --946K | --3.12M | ---1.92M |
| Net investment property transactions | ---- | ---- | ---6.02M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net investment product transactions | --0 | ---7.8M | 189.26%9.41M | 189.41%9.43M | --0 | ---16K | --0 | ---10.55M | ---10.55M | --0 |
| Advance cash and loans provided to other parties | ---286K | ---2K | ---2.75M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Dividends received (cash flow from investment activities) | ---- | ---- | --855K | --0 | --285K | ---- | ---- | --0 | --0 | --0 |
| Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.58M | ---- | ---- |
| Investing cash flow | -220.49%-38.6M | -1,706.44%-58.06M | -58.35%-97.05M | -51.33%-40.47M | -495.15%-41.33M | 5.96%-12.04M | 78.28%-3.21M | 55.22%-61.29M | 34.94%-26.74M | 89.42%-6.94M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 142.49%1.12M | -150.30%-3.54M | -54.97%30.69M | -632.40%-16.68M | 54.55%42.97M | -166.09%-2.63M | -81.81%7.03M | -30.48%68.15M | -106.93%-2.28M | -55.95%27.81M |
| Net common stock issuance | 676.05%73.03M | -47.85%17.68M | 3,556.44%74.04M | 1,116.78%16.76M | 6,056.39%13.98M | 2,135.15%9.41M | --33.9M | --2.03M | --1.38M | --227K |
| Net preferred stock issuance | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---7.2M | ---3.08M | --0 |
| Increase or decrease of lease financing | -9.94%-376K | -79.42%-872K | -8.86%-3.27M | 1.21%-898K | -124.13%-1.54M | 50.22%-342K | 32.31%-486K | -39.63%-3M | -38.36%-909K | -59.26%-688K |
| Cash dividends paid | ---- | ---- | ---492K | ---192K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash dividends for minorities | ---- | ---- | ---492K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other fund-raising expenses | 201.11%1.18M | -245.81%-2.4M | 1,838.08%109.86M | 2,218.31%113.01M | 93.20%-3.63M | -102.47%-1.17M | -67.81%1.65M | 4.02%-6.32M | -93.37%-5.34M | -6,974.14%-53.34M |
| Financing cash flow | 1,407.70%74.95M | -74.18%10.87M | 292.99%210.84M | 1,195.82%111.99M | 299.18%51.78M | -89.38%4.97M | -2.20%42.1M | -39.92%53.65M | -134.68%-10.22M | -141.97%-26M |
| Net cash flow | ||||||||||
| Beginning cash position | 113.79%209.79M | 44.21%87.24M | 64.41%60.49M | -15.52%56.7M | 11.24%76.56M | 244.44%98.13M | 64.41%60.49M | 31.28%36.79M | 224.15%67.12M | 26.02%68.82M |
| Current changes in cash | 87.67%-2.43M | 220.01%121.68M | 10.38%26.32M | 541.29%28.45M | -1,172.52%-20.42M | -148.71%-19.73M | 541.78%38.02M | 168.11%23.85M | -140.16%-6.45M | 95.25%-1.61M |
| Effect of exchange rate changes | 126.76%493K | 320.72%863K | 391.10%425K | 1,293.71%2.09M | 663.37%569K | -970.93%-1.84M | -229.47%-391K | -14.06%-146K | -614.71%-175K | 33.11%-101K |
| End cash Position | 171.50%207.85M | 113.79%209.79M | 44.21%87.24M | 44.21%87.24M | -15.52%56.7M | 11.24%76.56M | 244.44%98.13M | 64.41%60.49M | 64.41%60.49M | 224.15%67.12M |
| Free cash flow | -108.05%-50.66M | 4,370.71%152.64M | -617.39%-156.27M | -705.19%-67.79M | -344.85%-60.55M | -301.47%-24.35M | 93.08%-3.57M | 72.94%-21.78M | 183.24%11.2M | 125.85%24.73M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.